Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2005
12/01/2005WO2005067643A8 Determination of hepatitis c virus genotype
12/01/2005WO2005051330B1 METHOD FOR TREATING HUMAN TUMOR CELLS WITH A NEWCASTLE DISEASE VIRUS STRAIN HAVING A p53 INDEPENDENT ONCOLYTIC EFFECT
12/01/2005WO2005005614A3 Combined b-cell and t-cell epitopes on vlp for improved vaccines
12/01/2005WO2003049703A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/01/2005US20050266567 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
12/01/2005US20050266566 Viral vector in which gene for Sendai viral protein selected from NP, P, and L proteins is deleted or inactivated while all other gene functions are retained; use as expression vector in e.g. gene therapy; efficient system for reconstituting Sendai virus
12/01/2005US20050266564 Tetracycline-regulated gene expression in HSV-1 vectors
12/01/2005US20050266550 TC-83-derived alphavirus vectors, particles and methods
12/01/2005US20050266544 Methods and compositions for increasing viral vector production in packaging cell lines
12/01/2005US20050266439 Thermostable RNA ligase from thermus phage
12/01/2005US20050266400 Novel sequences encoding hepatitis C virus glycoproteins
12/01/2005US20050266026 Multi plasmid system for the production of influenza virus
12/01/2005US20050266023 Generation of virus-like particles and use as panfilovirus vaccine
12/01/2005US20050266020 Modular transport systems for molecular substances and production and use thereof
12/01/2005US20050266019 Infectious bursal disease virus antigenic isolates and vaccines
12/01/2005US20050265973 Chimeric adenoviruses for use in cancer treatment
12/01/2005US20050265972 A genetic construct containing a glucose inducible regulatory element with a pair of CACGTG nucleotide sequences and confer human proinsulin expression in host hepatocyte cells; therapy for diabetes
12/01/2005US20050265971 Agent for treatment of breast cancer and pancreatic cancer comprising herpes simplex virus mutant
12/01/2005CA2568248A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
12/01/2005CA2566858A1 Process for the production of an influenza vaccine
11/2005
11/30/2005EP1599592A1 Infectious flavivirus pseudo-particles containing functional prm and/or e proteins
11/30/2005EP1599581A2 Production of a live vaccine directed against influenza viruses
11/30/2005EP1599580A1 Animal-free cell culture method
11/30/2005EP1599495A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
11/30/2005EP1268766B1 Improvements to ribosome display
11/30/2005CN1702171A Recombinant herpes simplex virus capable of excreting angiostatin and endostatin protein and its application in treating lung cancer
11/30/2005CN1229501C Mixture of recombinant vaccinia vectors as poly-envelope protein vaccines for HIV
11/29/2005US6969598 Methods for producing high titre vectors and compositions used in such methods
11/29/2005CA2331599C Replication defective hiv vaccine
11/24/2005WO2005111201A1 Vaccine comprising an attenuated pestivirus
11/24/2005WO2005111200A1 Novel strains of reoviruses and methods of uses thereof
11/24/2005WO2005111199A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b
11/24/2005WO2005049077A3 Avian vaccine effective against infectious bursal disease virus
11/24/2005US20050261472 Binding moieties for fibrin
11/24/2005US20050261183 PTHrP-derived modulators of smooth muscle proliferation
11/24/2005US20050260734 Packaging cells
11/24/2005US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof
11/24/2005US20050260564 Non-cytotoxic oriP replicon
11/24/2005US20050260171 Compositions containing bacteriophages and method of using bacteriophages to treat infections
11/24/2005US20050260169 Treatment of cancer using HSV mutant
11/24/2005US20050260168 Compositions comprising viruses and methods for concentrating virus preparations
11/24/2005US20050260162 Conditionally replicative adenovirus to target the Rb and Rb-related pathways
11/24/2005US20050260156 Modified vaccinia virus ankara for the vaccination of neonates
11/24/2005DE102004020762A1 Preparation of an oncolytic virus suspension, useful for treating cancers, comprises inoculating tumor cell lines with viruses and selecting oncolytic viruses in the culture supernatant that can form syncitia
11/24/2005CA2567301A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b
11/24/2005CA2561719A1 Vaccine comprising an attenuated pestivirus
11/23/2005EP1598425A1 Modified Vaccinia Ankara virus variant
11/23/2005EP1598420A2 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases
11/23/2005EP1597376A2 Chicken rna polymerisate i promoter and the use thereof
11/23/2005EP1597359A1 Inactivated nodavirus vaccine
11/23/2005EP1226264B1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
11/23/2005EP1185628B1 Isolation of a human retrovirus
11/23/2005CN1699560A Extended-spectrum beta-lactamases Escherichia coli bacteriophage and its separation and preparation method
11/23/2005CN1699559A An imine-resistant bacillus pyocyaneus bacteriophage and its use for treating infection therefrom
11/23/2005CN1698430A Improved storage and maintenance of blood products
11/23/2005CN1228447C Recombinant expression vector expressing human pancreatic tissue kallikrein gene
11/23/2005CN1228085C Forest cerebritis purifying vaccine
11/22/2005CA2267639C Synthetic hpv16 virus-like particles
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108581A1 Recombinant virus vector for gene introduction in lymphocyte
11/17/2005WO2005108560A2 Synthesis and purification of west nile virus virus-like particles
11/17/2005WO2005107796A2 Cellular permissivity factor for viruses, and uses thereof
11/17/2005WO2005058356A3 Methods for porducing storage stable viruses and immunogenic compositions thereof
11/17/2005WO2004073736A8 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same
11/17/2005US20050255597 Transformation of cells with vector carrying transgenic virus
11/17/2005US20050255480 A norovirus-permissive cell culture, including dendritic- and macrophage-lineage cells and macrophages having a deficiency in a cellular anti-viral pathway such as a STAT-1-dependent pathway, an interferon receptor-dependent pathway, or a PKR-dependent pathway infected with a norovirus
11/17/2005US20050255461 Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
11/17/2005US20050255123 Chimeric ebola virus envelopes and uses therefor
11/17/2005US20050255089 adeno-associated virus 5 (AAV5) specific polynucleotides, that codes for an AAV5 specific proteins; delivering polynucleotides to cells using the AAV5 vectors and particles
11/17/2005US20050255085 Prevention of recurrence and metastasis of cancer
11/17/2005CA2565509A1 Recombinant virus vector for gene introduction in lymphocyte
11/17/2005CA2564769A1 Cellular permissivity factor for viruses, and uses thereof
11/16/2005EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/16/2005EP1498129B1 Use of adenoviruses mutated in the va genes for cancer treatment
11/16/2005EP1216053B1 Influenza vaccine
11/16/2005EP1062235B1 A method for isolating and purifying soluble proteins and peptides from plant sources
11/16/2005EP0741793B1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
11/16/2005CN1697884A Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
11/16/2005CN1697879A Biomolecule transfer method using virus envelope and composition and system therefor
11/15/2005US6964762 Composition and method for stimulating immune response to pathogen using complex adenoviral vector
11/15/2005CA2437962C Method of extracting virus from cell culture
11/15/2005CA2155533C Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
11/10/2005WO2005106046A1 Modified viral vector particles
11/10/2005WO2005105834A1 Method for the production of empty viral capsids in yeasts, said capsids comprising proteins derived from pvp2 of the virus that causes infectious bursal disease (ibdv)
11/10/2005US20050251872 Lentiviral vectors, related reagents, and methods of use thereof
11/10/2005US20050250206 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
11/10/2005US20050250114 Method for decreasing the number of free virus particles within the bodily fluids of a virally-infected mammal
11/10/2005US20050250105 Multiple viral replicon culture systems
11/10/2005US20050250093 Hepatitis c virus sub-genomic replicons
11/10/2005US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines
11/10/2005US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe
11/10/2005US20050247630 Methods for removal, purification, and concentration of viruses and methods of therapy based thereupon
11/09/2005EP1593738A1 Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier
11/09/2005EP1261693B1 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors
11/09/2005EP0812359B1 Group o hiv-1, fragments of such viruses, and uses thereof
11/09/2005CN1694958A Gene expression system based on codon translation efficiency
11/09/2005CN1694898A HBV precore protein capable of forming particles
11/09/2005CN1693455A Mosaic type swine circular ring virus PCV 1.2 and its construction method use
11/08/2005US6963021 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
11/08/2005US6962777 VLP-containing compositions produced express conformational, neutralizing epitopes and have high homogeneity and therefore comprise effective diagnostic and prophylactic agents for diagnosis or prevention of papillomavirus infections